Allianz Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,600
| Closed | -$555K | – | 1809 |
|
|
2025
Q1 | $555K | Buy |
63,600
+35,600
| +127% | +$311K | ﹤0.01% | 1391 |
|
|
2024
Q4 | $402K | Hold |
28,000
| – | – | ﹤0.01% | 1463 |
|
|
2024
Q3 | $632K | Buy |
+28,000
| New | +$632K | ﹤0.01% | 1360 |
|
|
2024
Q2 | – | Sell |
-6,200
| Closed | -$233K | – | 1750 |
|
|
2024
Q1 | $233K | Buy |
6,200
+600
| +11% | +$22.5K | ﹤0.01% | 1580 |
|
|
2023
Q4 | $313K | Buy |
+5,600
| New | +$313K | ﹤0.01% | 1504 |
|
|
2022
Q1 | – | Sell |
-141,261
| Closed | -$21M | – | 2109 |
|
|
2021
Q4 | $21M | Buy |
141,261
+9,174
| +7% | +$1.37M | 0.01% | 721 |
|
|
2021
Q3 | $19.2M | Buy |
132,087
+13,300
| +11% | +$1.94M | 0.01% | 710 |
|
|
2021
Q2 | $23.3M | Sell |
118,787
-20,883
| -15% | -$4.09M | 0.02% | 574 |
|
|
2021
Q1 | $25.3M | Buy |
139,670
+85,844
| +159% | +$15.5M | 0.02% | 523 |
|
|
2020
Q4 | $7.62M | Buy |
53,826
+9,813
| +22% | +$1.39M | 0.01% | 911 |
|
|
2020
Q3 | $5.49M | Buy |
44,013
+39,773
| +938% | +$4.96M | 0.01% | 937 |
|
|
2020
Q2 | $379K | Buy |
+4,240
| New | +$379K | ﹤0.01% | 1659 |
|